Arch Pharmalabs Limited Eyes $100M by 2010 from DSM Deal

December 4, 2007 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

MUMBAI, Dec 4 (Reuters) - India's Arch Pharma Labs expects to get at least $100 million by 2010 from the bulk drug manufacture deal it has entered with Dutch chemicals group DSM (DSMN.AS: Quote, Profile, Research), a top official said on Tuesday.

Twitter
LinkedIn
Facebook
Email
Print

Alliances Asia